Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial
Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.

Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.5.0. Removed Revision: v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label updated to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedUpdated revision from v3.4.1 to v3.4.2; no visible changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to content or functionality are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.